• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喹喔啉衍生物对AMPA受体拮抗作用的结构要求的计算机模拟研究

in Silico investigation of the structural requirements for the AMPA receptor antagonism by quinoxaline derivatives.

作者信息

Azam Faizul, Abugrain Ismaiel Mohamed, Sanalla Mohamed Hussin, Elnaas Radwan Fatahalla, Rajab Ibrahim Abdassalam Ibn

机构信息

Faculty of Pharmacy, Misurata University, PO Box 2873, Misurata, Libya.

出版信息

Bioinformation. 2013 Oct 16;9(17):864-9. doi: 10.6026/97320630009864. eCollection 2013.

DOI:10.6026/97320630009864
PMID:24250113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819572/
Abstract

Glutamate receptors have been implicated in various neurological disorders and their antagonism offers a suitable approach for the treatment of such disorders. The field of drug design and discovery aims to find best medicines to prevent, treat and cure diseases quickly and efficiently. In this regard, computational tools have helped medicinal chemists modify and optimize molecules to potent drug candidates with better pharmacokinetic profiles, and guiding biologists and pharmacologists to explore new disease genes as well as novel drug targets. In the present study, to understand the structural requirements for AMPA receptor antagonism, molecular docking study was performed on 41 structurally diverse antagonists based on quinoxaline nucleus. Lamarckian genetic algorithm methodology was employed for docking simulations using AutoDock 4.2 program. The results obtained signify that the molecular docking approach is reliable and produces a good correlation coefficient (r(2) = 0.6) between experimental and docking predicted AMPA receptor antagonistic activity. The aromatic moiety of quinoxaline core has been proved to be vital for hydrophobic contacts exhibiting - interactions in docked conformations. However, polar moieties such as carboxylic group and 1,2,4-triazole moieties were noted to be sites for hydrophilic interactions in terms of hydrogen bonding with the receptor. These analyses can be exploited to design and develop novel AMPA receptor antagonists for the treatment of different neurological disorders.

摘要

谷氨酸受体与多种神经系统疾病有关,对其进行拮抗作用为治疗此类疾病提供了一种合适的方法。药物设计与发现领域旨在找到能快速有效地预防、治疗和治愈疾病的最佳药物。在这方面,计算工具帮助药物化学家将分子修饰和优化为具有更好药代动力学特征的有效候选药物,并指导生物学家和药理学家探索新的疾病基因以及新的药物靶点。在本研究中,为了解AMPA受体拮抗作用的结构要求,对基于喹喔啉核的41种结构多样的拮抗剂进行了分子对接研究。使用AutoDock 4.2程序,采用拉马克遗传算法方法进行对接模拟。所得结果表明,分子对接方法是可靠的,并且在实验和对接预测的AMPA受体拮抗活性之间产生了良好的相关系数(r(2) = 0.6)。喹喔啉核心的芳香部分已被证明对于在对接构象中表现出 - 相互作用的疏水接触至关重要。然而,就与受体形成氢键而言,极性部分如羧基和1,2,4 - 三唑部分被认为是亲水相互作用的位点。这些分析可用于设计和开发用于治疗不同神经系统疾病的新型AMPA受体拮抗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/c3ee341b3955/97320630009864F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/d40f7fc48028/97320630009864F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/43412d791684/97320630009864F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/9852161c5d0e/97320630009864F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/c3ee341b3955/97320630009864F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/d40f7fc48028/97320630009864F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/43412d791684/97320630009864F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/9852161c5d0e/97320630009864F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790e/3819572/c3ee341b3955/97320630009864F4.jpg

相似文献

1
in Silico investigation of the structural requirements for the AMPA receptor antagonism by quinoxaline derivatives.喹喔啉衍生物对AMPA受体拮抗作用的结构要求的计算机模拟研究
Bioinformation. 2013 Oct 16;9(17):864-9. doi: 10.6026/97320630009864. eCollection 2013.
2
Molecular docking studies of 1-(substituted phenyl)-3-(naphtha [1, 2-d] thiazol-2-yl) urea/thiourea derivatives with human adenosine A(2A) receptor.1-(取代苯基)-3-(萘并[1,2-d]噻唑-2-基)脲/硫脲衍生物与人腺苷A(2A)受体的分子对接研究
Bioinformation. 2011;6(9):330-4. doi: 10.6026/97320630006330. Epub 2011 Jul 19.
3
Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.新型喹喔啉衍生物的设计、合成及抗HIV活性
Eur J Med Chem. 2016 Jul 19;117:230-40. doi: 10.1016/j.ejmech.2016.04.019. Epub 2016 Apr 11.
4
In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation.基于定量构效关系、分子对接和药代动力学参数计算预测苯并咪唑类促肾上腺皮质激素释放因子-1 受体拮抗剂的体内结合机制。
J Biomol Struct Dyn. 2018 May;36(7):1691-1712. doi: 10.1080/07391102.2017.1332688. Epub 2017 Jun 12.
5
Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson's disease: computational and structural insights.绿茶儿茶素作为治疗帕金森病的多靶点候选药物的分子相互作用研究:计算与结构见解
Network. 2015;26(3-4):97-115. doi: 10.3109/0954898X.2016.1146416. Epub 2016 Mar 30.
6
Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.喹喔啉衍生物:抑制N-甲基-D-天冬氨酸和非N-甲基-D-天冬氨酸受体介导的电流及突触电位的构效关系和生理意义
Mol Pharmacol. 1992 Feb;41(2):337-45.
7
Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.新型威拉地丁衍生物作为AMPA和海人藻酸受体拮抗剂的结构要求
Br J Pharmacol. 2003 Mar;138(6):1093-100. doi: 10.1038/sj.bjp.0705148.
8
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.犬尿喹啉酸衍生物。兴奋性氨基酸拮抗作用的构效关系以及N-甲基-D-天冬氨酸受体甘氨酸位点强效和选择性拮抗剂的鉴定。
J Med Chem. 1991 Apr;34(4):1243-52. doi: 10.1021/jm00108a002.
9
Identification of potential Gly/NMDA receptor antagonists by cheminformatics approach: a combination of pharmacophore modelling, virtual screening and molecular docking studies.通过化学信息学方法鉴定潜在的甘氨酸/ N-甲基-D-天冬氨酸受体拮抗剂:药效团建模、虚拟筛选和分子对接研究的结合
SAR QSAR Environ Res. 2016;27(2):125-45. doi: 10.1080/1062936X.2015.1136679.
10
Synthesis and biological evaluation of novel 9-heteroaryl substituted 7-chloro-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates (TQX) as (R,S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptor antagonists.
Chem Pharm Bull (Tokyo). 2008 Aug;56(8):1085-91. doi: 10.1248/cpb.56.1085.

引用本文的文献

1
3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment.用于安全有效炎症治疗的酪氨酸衍生物的三维结构相互作用和定量结构毒性研究。
Chem Cent J. 2016 Apr 30;10:24. doi: 10.1186/s13065-016-0169-9. eCollection 2016.

本文引用的文献

1
Safety and tolerability of perampanel: a review of clinical trial data.吡仑帕奈的安全性与耐受性:临床试验数据综述
Acta Neurol Scand Suppl. 2013(197):30-5. doi: 10.1111/ane.12102.
2
Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease.用于治疗帕金森病的阻断单胺氧化酶-B和腺苷A(2A)受体的双机制药物的分子对接及药代动力学性质预测
J Young Pharm. 2012 Jul;4(3):184-92. doi: 10.4103/0975-1483.100027.
3
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
吡仑帕奈,一种选择性、非竞争性的α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体拮抗剂,作为难治性部分发作性癫痫的辅助治疗:III 期、扩展研究 307 的中期结果。
Epilepsia. 2013 Jan;54(1):126-34. doi: 10.1111/j.1528-1167.2012.03648.x. Epub 2012 Aug 20.
4
Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents.基于结构的设计、合成及噻唑基脲衍生物的分子模拟研究作为新型抗帕金森药物。
Med Chem. 2012 Nov;8(6):1057-68. doi: 10.2174/1573406411208061057.
5
Targeting oxidative stress component in the therapeutics of epilepsy.针对癫痫治疗中的氧化应激成分。
Curr Top Med Chem. 2012;12(9):994-1007. doi: 10.2174/156802612800229224.
6
Molecular docking studies of 1-(substituted phenyl)-3-(naphtha [1, 2-d] thiazol-2-yl) urea/thiourea derivatives with human adenosine A(2A) receptor.1-(取代苯基)-3-(萘并[1,2-d]噻唑-2-基)脲/硫脲衍生物与人腺苷A(2A)受体的分子对接研究
Bioinformation. 2011;6(9):330-4. doi: 10.6026/97320630006330. Epub 2011 Jul 19.
7
Molecular structure of ionotropic glutamate receptors.离子型谷氨酸受体的分子结构。
Curr Med Chem. 2010;17(24):2608-35. doi: 10.2174/092986710791859379.
8
Design, synthesis and anti-Parkinsonian evaluation of 3-alkyl/aryl-8-(furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones against neuroleptic-induced catalepsy and oxidative stress in mice.设计、合成和抗帕金森病评价 3-烷基/芳基-8-(呋喃-2-基)噻唑并[5,4-e][1,2,4]三唑并[1,5-c]嘧啶-2(3H)-硫酮对小鼠神经安定剂诱导的僵住和氧化应激的作用。
J Enzyme Inhib Med Chem. 2010 Dec;25(6):818-26. doi: 10.3109/14756361003671052. Epub 2010 Apr 30.
9
Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides.抗癫痫氧化应激:1-(取代亚苄基/亚乙基)-4-(萘-1-基)缩氨基脲的设计、合成、量子化学研究和抗惊厥评价。
Eur J Med Chem. 2010 Jul;45(7):2817-26. doi: 10.1016/j.ejmech.2010.02.063. Epub 2010 Mar 7.
10
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)拮抗剂:从实验台到病床边
J Med Chem. 2010 Aug 12;53(15):5367-82. doi: 10.1021/jm901688m.